Tag: the war on (some) drugs

New Study: Cannabis Use Tied To Higher Physical Activity, Dispelling Myth of Lazy Stoner

A just released new study on Cannabis use and physical activity dispels myt of lazy stoners. A new study shows that contrary to lazy stoner stereotypes, legal medical marijuana “promotes greater physical activity” in people with chronic medical conditions and that “legal recreational cannabis promotes (even more so) greater physical activity in those not experiencing chronic medical conditions.”

Per the study, activity increased from 73.16% in 2016 to 75.72% in 2022 (3.5% increase) and current cannabis use increased from 7.48% in 2016 to 14.71% in 2022 (96.7% increase). Current cannabis use was 6.5% higher in areas of legalized recreational cannabis (vs. not legal) and 0.7% higher in areas of legalized medical cannabis (vs. not legal). For the combined years, the OR measuring the association between cannabis use and physical activity was 1.24 (95% CI 1.10–1.41), after adjusting for age, sex, race/ethnicity, marital status, employment status, education, smoking status, weight classification, legal status, and chronic medical condition. The adjusted OR was 1.47 (95% CI 1.34–1.62) in areas with legalized recreational and medical cannabis (vs. illegal) and 1.05 (95% CI 0.98–1.12) in areas with legalized medical cannabis only (vs. illegal). Having a medical condition was significantly associated with lower prevalence of physical activity in the adjusted models (overall adjusted OR = 0.79, 95% CI 0.73–0.85). However, this significantly lower odds ratio was insignificant for current cannabis users.

An online survey of 605 current adult cannabis users found that 81.7% endorsed using cannabis simultaneously with exercise (YorkWilliams et al. 2019). Those who used cannabis concurrently with exercise were more likely to be younger (mean age 36.3 [SD = 14.9] vs. 43.1 [SD = 18.0]) and male. After adjusting for age and sex, those who used cannabis concurrently with exercise engaged in more minutes of aerobic and anaerobic exercise per week than those who did not. A majority also endorsed using cannabis before or after exercise, indicating that it enhanced enjoyment and recovery from exercise. Approximately half of the participants said that it increased their motivation to exercise.

With legalization of cannabis increasing in recent decades, there is greater potential for people to combine cannabis with physical activity. In 2016, cannabis use was legal for recreational and medical use in 17% of the U.S. states and territories and for medical use only in 43% of the area. In 2022, corresponding values were 41% and 36%. Hence, cannabis was legal at some level in 60% of the areas in 2016 and 77% of the areas in 2022. Consequently, the prevalence of cannabis use in adults increased from 7.48% in 2016 to 14.71% in 2022. Further, during 2016–2022 the prevalence of cannabis use was 9% higher in areas where medical cannabis only was legal and 81% higher in areas where recreational cannabis was legal (vs. not legal) (Merrill 2024). Of interest is whether the prevalence of being physically active is greater in areas with legalized cannabis for recreational and medical (vs. illegal) and medical only (vs. illegal).

Having a chronic medical condition such as arthritis may limit physical activity because of pain and other possible problems. People with arthritis may be concerned that physical activity might worsen their pain or joint damage, or they may not know what activities are safe (Wilcox et al. 2006). However, if cannabis use is perceived to help lower arthritis pain and other potential problems such as inflammation, it may correspond with increased physical activity among these patients. Indeed, recent research has found that CBD treatment can reduce pain and inflammation-causing fibroblasts in rheumatoid arthritis (Lowin et al. 2020; Frane et al. 2022). Hence, of interest is whether the association between having a chronic medical condition and physical activity is moderated by current cannabis use.

Keep reading

After Locking Up 1000s For Weed Possession, Kamala Harris Patronizes Black Men In Pot Pandering Scheme

On track to post Democrats’ worst presidential-election performance with blacks in 64 years, a desperate Kamala Harris smashed the vote-buying button on Monday, proposing an “Opportunity Agenda” for black men that includes dishing out one million “forgivable loans” at $20,000 each. 

The loans would be offered to black entrepreneurs “in partnership with trusted organizations like mission-driven lenders and banks with a proven commitment to their communities,” the Harris-Walz campaign said. If these “forgivable loans” are anything like the ones dished out to businesses during the madness of Covid stimulus, they’ll be loans in name only — meaning this is just a blatant wealth redistribution scheme aimed at buying black votes.  

Unsurprisingly, the campaign provided few details about the program’s requirements — such as just how black one will need to be to qualify.

The pledge comically evidences Harris’ generationally-terrible poll numbers among blacks. Consider that, in 2012, President Obama owned the black vote by an 85-point margin. Today, Harris is up by just 54 points. The numbers are even worse among black men age 18 to 45: Obama won by 81, and Harris is up 41. Among all black men and women, Harris is poised to have the lowest share of the black vote since John F. Kennedy faced Richard Nixon in 1960.  

Keep reading

Medical Marijuana Availability Improves Mental Health In Older People, Research Finds

Medical marijuana being legally available “improved self-reported mental health among people aged 65 years and older,” according to a new study.

Among adults overall, “medical cannabis availability was not associated with self-reported poor mental health,” it adds. “Collectively, these results suggest medical cannabis availability has limited mental health effects on the population at large, with considerable mental health benefits for older adults.”

For people 65 and older, authors noted that living within 30 minutes of a dispensary “decreased the probability having a poor mental health day in the past month by about 10 percent,” which they point out was “a 3.5 percentage point decrease from an original probability of roughly 36 percent.”

“What may explain our finding that medical cannabis availability improves the self-reported mental health of people aged 65 and above? Likely pain relief,” the research brief from authors at the libertarian Cato Institute says. “Cannabis is a good treatment for chronic pain caused by nerve disease (neuropathy)—the most common justification for medical cannabis and a common chronic condition among older adults.”

The study used geographic data to” estimate medical cannabis dispensary availability’s effects on self-reported mental health in New York state from 2011 through 2021 using a two-stage difference-in-differences approach to minimize bias introduced from the staggered opening of dispensaries,” the paper says.

Keep reading

The Remarkable History and Safety of DMSO

My time in the medical field has led me to accept many medical practices are adopted because of politics or economics rather than because existing evidence shows they work. Nonetheless, certain instances of this happening still astound me to this day, particularly the blacklisting of DMSO (dimethyl sulfoxide) as:

•This simple chemical is incredibly safe and effective and treats a wide range of challenging medical conditions that impact millions that still lack an effective therapy (outside of DMSO).

•Because of its efficacy, once discovered, it took the country by storm, resulting in millions using it, the scientific community getting behind it and publishing thousands of studies on DMSO, numerous pharmaceutical companies making large investments to bring it market, professional athletes promoting it, numerous governors, congressional representatives and senators (on behalf of both themselves and their constituents) pressuring the FDA to give it a fair chance for decades and state legislatures independently legalizing it because the federal government would not.

•Many approved pharmaceutical products take advantage of DMSO’s properties to work (e.g., in those products, DMSO is often classified as an inert “vehicle”). Similarly, DMSO is FDA approved for one condition (interstitial cystitis) and is approved for a wide variety of veterinary uses (e.g., the same conditions it treats in humans).

•Over the past 40 years, more than 10,000 articles on the biological implications and 30,000 articles on the chemistry of DMSO have appeared in the scientific literature—much of which, as I’ve shown here is remarkably compelling and paradigm shifting in healthcare.

•Yet, despite all of that, DMSO was effectively erased from history. It is now widely seen as an unproven and dangerous therapy, and even within the natural health field, most people do not know it exists.

Because of all that, I’ve felt a responsibility to use this platform to get the knowledge on DMSO out, which I began by presenting the strong case that DMSO is an incredible therapy for:

•Circulatory disorders like Reynaud’s and varicose veins.
•A wide range of neurological disorders, including ischemic and hemorrhagic strokes, and spinal cord injuries leading to paralysis or dementia.
•Allowing patients who’ve had decades of chronic pain (from a variety of different causes) to get their lives back.
•Healing a wide range of injuries (e.g., sports injuries, traumatic impacts) and chronic musculoskeletal problems (e.g., spine and shoulder issues) and wounds (e.g., burns or surgical incisions).
•Chronic rheumatic conditions (e.g., arthritis).
•Complex protein disorders (e.g., amyloidosis).
•Down Syndrome.

In turn, I’ve received numerous reports from readers (I’ve been gradually sharing here) from readers who’ve experienced rapid life-changing benefits from DMSO, very similar to the data I provided, which showed DMSO had an 80-90% success rate in treating.

Keep reading

Most People Don’t Trust The Government For Marijuana Information, Federally Funded Study Shows

American adults typically don’t get their information about about marijuana from government or medical sources, instead relying mostly on friends and family, according to a new study that was partially funded by a federal agency.

The nationally representative survey of 1,161 adults found that government agencies were the least popular source of cannabis-related information (4.7 percent in the probability-weighted results). And while health and medical care providers were also among the least common sources, at 9.3 percent, they were higher on the list than budtenders (8.6 percent).

The most popular sources of marijuana information, meanwhile, were friends and family (35.6 percent) and websites (33.7 percent).

The study, which received support from the National Institute on Drug Abuse and was published this month in the Journal of Cannabis Research, concludes that most people “draw healthcare information about cannabis from friends and family or online, with very few consulting their healthcare provider or government agencies.”

Notably, people who reported using cannabis for medical reasons were significantly more likely than others to cite healthcare professionals as a source of their marijuana-related information compared to other respondents (16.4 percent versus 5.2 percent, respectively).

Given the trend toward liberalization of cannabis policies in the U.S.—and what the paper describes as potentially “broad effects on public health outcomes related to cannabis” if marijuana is moved from Schedule I to Schedule III of the federal Controlled Substances Act—the paper urges more attention to ensuring healthcare providers are educated on cannabis-related matters and that government messaging is handled with care.

“As cannabis accessibility and legality is increasing,” it says, “there is a strong need for better clinician education, public outreach strategies, and improved communication between patients and clinicians about cannabis.”

NORML Deputy Director Paul Armentano said of the new survey findings that cannabis use “is not a new phenomenon and is not going away” and that sources like healthcare providers and government agencies have a responsibility to seek out and provide accurate information.

Keep reading

JD Vance Says ‘Bags Of Marijuana’ And Candy Laced With THC And Fentanyl Are Coming Across The Border, Blaming Biden-Harris Immigration Policy

Former President Donald Trump’s 2024 running mate, Sen. JD Vance (R-OH), is accusing Vice President Kamala Harris of failing to stop marijuana and fentanyl disguised as Nerds candy and other popular brands that appeal to children from coming across the border.

At a Faith & Freedom Coalition event in Atlanta last month, the senator talked about being invited to the evidence room of a sheriffs department where he says he saw “every drug you can possibly imagine,” including “bags and bags of marijuana,” pressed fentanyl pills and meth.

“I say, ‘Guys, what is going on here? You’ve got all these drugs here that looks to me just like a box of candy—a box of Nerds candy,” Vance said. “And they say, ‘Well, sir, that’s actually THC and fentanyl.’ But I say, ‘Wait a second, the cartels have disguised deadly fentanyl to look like child’s candy so that they can make it easier to get into our country?’”

“Yet we know that one of those packets of fentanyl is going to end up in one of our neighborhood streets,” he said. “One of those packets of fentanyl is going to end up in a child’s playground. One of those packets of what looks like Nerds candy, but is actually a deadly substance, is going to end up in our schools, and a kid’s going to open up a packet of candy, take a piece of candy out and lose their life because of it.”

“Now that is a sick and deranged human being that would do anything like that. But it’s a sick and deranged human being who would give that person power over the United States of America, and that’s exactly what Kamala Harris has done,” he said. “She has given these drug cartels free reign over our country, and now they’re smuggling in deadly drugs that look like child candy.”

Keep reading

New Mexico Officials Approve Medical Marijuana As A Treatment For Female Orgasm Difficulty

A New Mexico regulatory board has given preliminary approval to make female orgasm difficulty (FOD) a qualifying condition for the state’s medical marijuana program, voting 7–2 to recommend the change at a meeting on Monday.

The New Mexico Medical Cannabis Advisory Board’s vote does not immediately add FOD as a qualifying condition. A report with the board’s recommendation will next go to the secretary of health, who will review the proposal and consult with staff before either accepting, denying or modifying the recommendation.

That’s according to an email from the acting director of the New Mexico Department of Health’s Center for Medical Cannabis forwarded to Marijuana Moment by Suzanne Mulvehill, a clinical sexologist and researcher who’s helped lead the charge to add FOD as a qualifying condition in a number of states with legal cannabis.

Mulvehill told Marijuana Moment that she’s “very pleased” with the movement in New Mexico, noting that officials in Connecticut and Illinois have also taken steps to add FOD as qualifying conditions in those jurisdictions.

“FOD affects millions of women worldwide,” she added, “and there are no conventional treatments.”

Two additional states are currently considering adding FOD as a medical marijuana qualifying condition. Oregon held a virtual public meeting earlier this month and is accepting public comments through Friday. And in Arkansas, which held a public meeting about FOD last month, officials are taking comments until October 14.

Keep reading

‘Lesser-Known’ Marijuana Components Like CBG And THCV Are ‘Promising’ Treatments For Parkinson’s And Alzheimer’s, Study Shows

A new scientific review on the potential benefits of marijuana in treating brain disorders says that in addition to THC and CBD produced by the cannabis plant, “a diverse array of lesser-known phytocannabinoids, along with terpenes, flavonoids, and alkaloids” may also “demonstrate diverse pharmacological activities” and could offer therapeutic applications.

Such compounds include THCV, CBDV and CBG.

“Their antioxidant, anti-inflammatory and neuromodulatory effects position them as promising agents in treating neurodegenerative disorders,” says the report, authored by a pair of researchers from the Center for Dementia Research at the Nathan Kline Institute for Psychiatric Research in New York and released last month through Preprints.org.

Authors evaluated available scientific literature about minor cannabinoids and conditions such as epilepsy, Parkinson’s disease, Alzheimer’s disease, Huntington’s disease and substance and alcohol use disorders. They found evidence not only of neuroprotective effects but also other beneficial outcomes.

“The therapeutic potential of Cannabis sativa extends well beyond the widely studied CBD,” the report says, “encompassing a diverse range of lesser‐known phytocannabinoids that show promise in addressing various neurological disorders.”

“While research has extensively examined the neuropsychiatric and neuroprotective effects of Δ9-THC,” it adds, “other minor phytocannabinoids remain underexplored.”

Keep reading

Florida Senator Sues State Over Anti-Marijuana Ad, Alleging Unconstitutional Use Of Taxpayer Dollars Ahead Of Legalization Vote

A Florida Democratic senator is suing the state for using taxpayer dollars to fund a recent ad that he says unconstitutionally attempts to influence voters to oppose a marijuana legalization initiative that will be on the ballot next month.

Sen. Jason Pizzo (D), who is expected to run for governor in 2026, announced on Friday that he would be seeking an injunction against the Florida Department of Transportation (FDOT) over the ad, which warns against driving under the influence of cannabis and then makes a contested claim that “DUI crashes increase in states with legalized marijuana, putting everyone at risk.”

Making such an assertion in an ad supported by tax dollars amounts to “political messaging” and therefore represents an unconstitutional use of appropriations authority, the senator says. The campaign behind the Florida legalization initiative has also sent cease and desist letters to 54 TV stations that have aired the public service announcement.

“For years, our state has wasted precious time, and many millions, peddling divisive and unproductive nonsense, while flouting practical solutions for critical needs,” Pizzo said.

Keep reading

Marijuana Components Show ‘Promising Potential As Anticancer Agents,’ Study Finds, Though Mechanisms Of Action Are Still A Mystery

A new scientific review on cannabis and cancer concludes that a variety of cannabinoids—including delta-9 THC, CBD and cannabigerol (CBG)—”show promising potential as anticancer agents through various mechanisms,” for example by limiting the growth and spread of tumors.

But authors acknowledged that obstacles to incorporating cannabis into cancer treatment remain, such as regulatory barriers and the need to determine optimal dosing.

“Cannabinoids, including Δ9-THC, CBD, and CBG, exhibit significant anticancer activities such as apoptosis induction, autophagy stimulation, cell cycle arrest, anti-proliferation, anti-angiogenesis, and metastasis inhibition,” says the report, published late last month in the journal Discover Oncology. “Clinical trials have demonstrated cannabinoids’ efficacy in tumor regression and health improvement in palliative care.”

The workings behind those apparent benefits, however, are still largely unknown. “Despite the evident anti-cancer properties of cannabinoids from numerous experimental results,” the review says, “the exact mechanisms of action still require extensive research.”

It adds: “Despite the positive outcomes of using cannabinoids in cancer therapy, there remain significant gaps in knowledge regarding their modes of action, effects on the tumor microenvironment, and the physiology of the signaling pathways they affect.”

Keep reading